Generative AI Use Among Cancer Patients and Caregivers — Awareness, Attitudes, and the "Silent Usage" Problem
OVERVIEWA cross-sectional study of generative AI use among individuals with cancer and their caregivers found that usage remains moderate and largely undisclosed — a phenomenon the authors term "silent usage." The study identifies a distinct digital divide based on education and age, with higher-educated and younger individuals more likely to use and disclose AI tool use. A key clinical finding is that while patients and caregivers desire physician-verified AI tools, they are not proactively disclosing their AI use to oncologists. This creates a clinical blind spot: oncologists may be unaware that patients are using AI-generated information to interpret diagnoses, evaluate treatment options, or assess side effects, making it impossible to correct misinformation or integrate AI-sourced information into care planning. The authors recommend that oncologists proactively invite open, non-judgmental discussions about AI usage to clinically verify patients' findings, mitigate misinformation risks, and ensure safe integration into clinical practice. This recommendation positions AI disclosure as a clinical communication competency rather than a patient responsibility — a framing with implications for medical education, clinical protocols, and the design of physician-patient AI disclosure frameworks. The "silent usage" concept adds an important behavioral dimension to existing coverage of shadow health systems built on unregulated generative AI chatbots. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.